PRIOR TO PHASE III PSORIASIS DATA RELEASE CAN FITE REPORTS THAT PICLIDENOSON DESTROYS PATHOLOGICAL SKIN CELLS IN VITRO
Sponsored
Can-Fite to Conduct Investor Meetings during the J.P. Morgan Healthcare Conference
Sponsored
Dawson James - Can-Fite (CANF) Buy Rated - Expected Milestones
Sponsored
CAN-FITE ISSUES LETTER TO SHAREHOLDERS
Sponsored
FOLLOWING COMPLETE CLEARANCE OF CANCER LESIONS IN ADVANCED LIVER CANCER PATIENT, CAN-FITE IS FILING PATENT APPLICATIONS FOR THE TREATMENT OF VARIOUS ADVANCED SOLID TUMORS
Sponsored
Positive Data from Phase IIa Can-Fite NASH Study Published in Leading Peer Reviewed Scientific Journal
Sponsored